Delivery Order SPE2DB20D1100-SPE2DB25FE4J7
- Not listed
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of July 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a single transaction within the...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. The contract, awarded on July 18, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 18, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a continuation of the company's extensive federal pharmaceutical supply...
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of October 14, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 17, 2025. This firm fixed-price delivery order, issued on August 26, 2025, was competitively awarded without set-aside designation and represents a pediatric delivery against AmerisourceBergen's larger pharmaceutical supply agreement with the agency. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a $3,858.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 4, 2025. This non-set-aside contract represents a competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery will be fulfilled at AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Nemluvio 30 mg pens, with a completion date of September 10, 2025. This delivery order contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with a ceiling value of $1,929.20. This contract, awarded on September 4, 2025, with an ultimate completion date of September 25, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters....
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4J7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded, firm fixed-price contract was issued on September 3, 2025, with an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly supplies critical medical commodities to federal customers including the Defense Health Agency and U.S. Coast Guard through its DLA prime contract. The company's federal procurement history demonstrates consistent capability in delivering a broad range of pharmaceutical products across multiple therapeutic domains under competitive, firm fixed-price delivery orders. This particular award for Nemluvio 30 mg pens reflects the company's role as a primary supplier of specialty medications and brand-name pharmaceuticals supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/3/25 |